These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8783607)

  • 1. Reversal of left-ventricular hypertrophy in uremic patients by treatment with daily hemodialysis (DHD).
    Buoncristiani U; Fagugli RM; Pinciaroli MR; Kulurianu H; Ceravolo G; Bova C
    Contrib Nephrol; 1996; 119():152-6. PubMed ID: 8783607
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac and vascular structure and function parameters do not improve with alternate nightly home hemodialysis: an interventional cohort study.
    van Eps CL; Jeffriess L; Haluska B; Hawley CM; Coombes J; Matsumoto A; Jeffries JK; Johnson DW; Campbell SB; Isbel NM; Mudge DW; Marwick T
    BMC Nephrol; 2011 Oct; 12():51. PubMed ID: 21962236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clues for understanding the pathogenesis of left ventricular hypertrophy in chronic uremia.
    Cannella G; Paoletti E
    Int J Artif Organs; 1998 Jul; 21(7):378-83. PubMed ID: 9745991
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of nocturnal hemodialysis on peripheral uremic neuropathy.
    Ghazan-Shahi S; Koh TJ; Chan CT
    BMC Nephrol; 2015 Aug; 16():134. PubMed ID: 26264143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an increase in time vs. frequency on cardiovascular parameters in chronic hemodialysis patients.
    Weinreich T; De los Ríos T; Gauly A; Passlick-Deetjen J
    Clin Nephrol; 2006 Dec; 66(6):433-9. PubMed ID: 17176915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disorders of left ventricular structure and function in chronic uremia: how often, why and what to do with it?
    Dyadyk OI; Bagriy AE; Yarovaya NF
    Eur J Heart Fail; 1999 Dec; 1(4):327-36. PubMed ID: 10937946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.
    McCullough PA; Chan CT; Weinhandl ED; Burkart JM; Bakris GL
    Am J Kidney Dis; 2016 Nov; 68(5S1):S5-S14. PubMed ID: 27772643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study.
    Fagugli RM; Pasini P; Pasticci F; Ciao G; Cicconi B; Buoncristiani U
    J Nephrol; 2006; 19(1):77-83. PubMed ID: 16523430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive Home Hemodialysis Results in Regression of Left Ventricular Hypertrophy and Better Clinical Outcomes.
    Trinh E; Chan CT
    Am J Nephrol; 2016; 44(4):300-307. PubMed ID: 27640181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for left ventricular hypertrophy in chronic hemodialysis patients.
    Washio M; Okuda S; Mizoue T; Kiyama S; Ando T; Sanai T; Hirakata H; Nanishi F; Kiyohara C; Ogimoto I; Yoshimura T; Fujishima M
    Clin Nephrol; 1997 Jun; 47(6):362-6. PubMed ID: 9202865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of correcting anemia with recombinant erythropoietin on the central hemodynamic indices of patients on regular hemodialysis].
    Ermolenko VM; Khvoĭnitskiĭ VA; Suprun EK; Tsukerman LI; Pokrovskiĭ IuA
    Ter Arkh; 1992; 64(7):86-8. PubMed ID: 1440377
    [No Abstract]   [Full Text] [Related]  

  • 12. Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients.
    Fagugli RM; Reboldi G; Quintaliani G; Pasini P; Ciao G; Cicconi B; Pasticci F; Kaufman JM; Buoncristiani U
    Am J Kidney Dis; 2001 Aug; 38(2):371-6. PubMed ID: 11479164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis.
    Chan CT; Floras JS; Miller JA; Richardson RM; Pierratos A
    Kidney Int; 2002 Jun; 61(6):2235-9. PubMed ID: 12028465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of dialysis modality on the appropriateness of left ventricular mass in patients with end-stage renal disease.
    Paneni F; Gregori M; Ciavarella GM; Sciarretta S; Tocci G; Palano F; Domenici A; Punzo G; De Biase L; Menè P; Volpe M
    Int J Cardiol; 2011 Jun; 149(2):250-252. PubMed ID: 21392833
    [No Abstract]   [Full Text] [Related]  

  • 15. Hospitalization rates in daily home hemodialysis versus peritoneal dialysis patients in the United States.
    Kumar VA; Ledezma ML; Idroos ML; Burchette RJ; Rasgon SA
    Am J Kidney Dis; 2008 Oct; 52(4):737-44. PubMed ID: 18752877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily hemodialysis improves uremia-associated clinical parameters in the short term.
    Kojima E; Hoshi H; Watanabe Y; Takenaka T; Suzuki H
    Contrib Nephrol; 2012; 177():169-177. PubMed ID: 22613928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac mortality prevention in uremic patients. Therapeutic strategies with particular attention to complete correction of renal anemia.
    Berweck S; Hennig L; Sternberg C; Dingerkus H; Ludat K; Hampl H
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S80-5. PubMed ID: 10746811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of chronic uremic patients: a critical situation].
    Crosnier J; Kreis H
    Bull Acad Natl Med; 1982 Jun; 166(6):791-6. PubMed ID: 6756593
    [No Abstract]   [Full Text] [Related]  

  • 19. Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients.
    Cannella G; Paoletti E; Ravera G; Cassottana P; Araghi P; Mulas D; Peloso G; Delfino R; Messa P
    Kidney Int; 2000 Jul; 58(1):260-8. PubMed ID: 10886571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial.
    Rocco MV; Lockridge RS; Beck GJ; Eggers PW; Gassman JJ; Greene T; Larive B; Chan CT; Chertow GM; Copland M; Hoy CD; Lindsay RM; Levin NW; Ornt DB; Pierratos A; Pipkin MF; Rajagopalan S; Stokes JB; Unruh ML; Star RA; Kliger AS; ; Kliger A; Eggers P; Briggs J; Hostetter T; Narva A; Star R; Augustine B; Mohr P; Beck G; Fu Z; Gassman J; Greene T; Daugirdas J; Hunsicker L; Larive B; Li M; Mackrell J; Wiggins K; Sherer S; Weiss B; Rajagopalan S; Sanz J; Dellagrottaglie S; Kariisa M; Tran T; West J; Unruh M; Keene R; Schlarb J; Chan C; McGrath-Chong M; Frome R; Higgins H; Ke S; Mandaci O; Owens C; Snell C; Eknoyan G; Appel L; Cheung A; Derse A; Kramer C; Geller N; Grimm R; Henderson L; Prichard S; Roecker E; Rocco M; Miller B; Riley J; Schuessler R; Lockridge R; Pipkin M; Peterson C; Hoy C; Fensterer A; Steigerwald D; Stokes J; Somers D; Hilkin A; Lilli K; Wallace W; Franzwa B; Waterman E; Chan C; McGrath-Chong M; Copland M; Levin A; Sioson L; Cabezon E; Kwan S; Roger D; Lindsay R; Suri R; Champagne J; Bullas R; Garg A; Mazzorato A; Spanner E; Rocco M; Burkart J; Moossavi S; Mauck V; Kaufman T; Pierratos A; Chan W; Regozo K; Kwok S
    Kidney Int; 2011 Nov; 80(10):1080-91. PubMed ID: 21775973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.